FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by α1(IV)NC1

Chandra S. Boosani, Narasimharao Nalabothula, Veerendra Munugalavadla, Dominic E Cosgrove, Venkateshwar G. Keshamoun, Nader Sheibani, Akulapalli Sudhakar

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

PURPOSE. To determine the impact of the antiangiogenic factor α1(IV)NC1 on vascular endothelial growth factor-mediated proangiogenic activity in mouse retinal endothelial cells (MRECs). METHODS. Primary culture of MRECs was established as previously described and was used to determine the effects of α1(IV)NC1 on the proangiogenic activity of VEGF. Cell proliferation was evaluated using [3H]-thymidine incorporation and 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide colorimetric assays. Cell migration was determined using modified Boyden chamber and scratch wound assays and tube formation was assessed on basement membrane matrix (BMM). Intracellular signaling events Bcl-2/Bcl-xL and caspase-3/poly (ADP-ribose) polymerase (PARP) activities were evaluated in cells stimulated with VEGF and plated on type IV collagencoated dishes. Apoptosis was assessed by measuring caspase activity and by performing quantitative fluorescence analysis using fluorescence-activated cell sorting assay. Subcutaneously injected VEGF induced in vivo neovascularization was studied with the BMM plug assay. RESULTS. VEGF-induced subconfluent MREC proliferation, migration, and tube formation were significantly inhibited by α1(IV)NC1 at 1 μM (P < 0.001). α1(IV)NC1 induced MREC apoptosis is mediated by inhibition of Bcl-2 and Bcl-xL expression and activation of caspase-3/PARP through FAK/p38-MAPK signaling. In addition, α1(IV)NC1 dose dependently inhibited VEGF-mediated neovascularization in vivo. CONCLUSIONS. α1(IV)NC1 inhibited VEGF-mediated angiogenesis by promoting apoptosis and caspase-3/PARP activation and by negatively impacting FAK/p38-MAPK phosphorylation, Bcl-2, and Bcl-xL expression leading to MREC death. The endothelial- specific inhibitory actions of recombinant α1(IV)NC1 may be of benefit in the treatment of a variety of eye diseases with a neovascular component.

Original languageEnglish (US)
Pages (from-to)4567-4575
Number of pages9
JournalInvestigative Ophthalmology and Visual Science
Volume50
Issue number10
DOIs
StatePublished - Dec 1 2009

Fingerprint

p38 Mitogen-Activated Protein Kinases
Caspase 3
Vascular Endothelial Growth Factor A
Endothelial Cells
Apoptosis
Poly(ADP-ribose) Polymerases
Basement Membrane
Cell Movement
Cell Proliferation
Eye Diseases
Caspases
Thymidine
Flow Cytometry
Cell Death
Fluorescence
Phosphorylation
Wounds and Injuries

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by α1(IV)NC1. / Boosani, Chandra S.; Nalabothula, Narasimharao; Munugalavadla, Veerendra; Cosgrove, Dominic E; Keshamoun, Venkateshwar G.; Sheibani, Nader; Sudhakar, Akulapalli.

In: Investigative Ophthalmology and Visual Science, Vol. 50, No. 10, 01.12.2009, p. 4567-4575.

Research output: Contribution to journalArticle

Boosani, Chandra S. ; Nalabothula, Narasimharao ; Munugalavadla, Veerendra ; Cosgrove, Dominic E ; Keshamoun, Venkateshwar G. ; Sheibani, Nader ; Sudhakar, Akulapalli. / FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by α1(IV)NC1. In: Investigative Ophthalmology and Visual Science. 2009 ; Vol. 50, No. 10. pp. 4567-4575.
@article{b24ff1b4b16d49fdb8daf2cef9e855f9,
title = "FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by α1(IV)NC1",
abstract = "PURPOSE. To determine the impact of the antiangiogenic factor α1(IV)NC1 on vascular endothelial growth factor-mediated proangiogenic activity in mouse retinal endothelial cells (MRECs). METHODS. Primary culture of MRECs was established as previously described and was used to determine the effects of α1(IV)NC1 on the proangiogenic activity of VEGF. Cell proliferation was evaluated using [3H]-thymidine incorporation and 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide colorimetric assays. Cell migration was determined using modified Boyden chamber and scratch wound assays and tube formation was assessed on basement membrane matrix (BMM). Intracellular signaling events Bcl-2/Bcl-xL and caspase-3/poly (ADP-ribose) polymerase (PARP) activities were evaluated in cells stimulated with VEGF and plated on type IV collagencoated dishes. Apoptosis was assessed by measuring caspase activity and by performing quantitative fluorescence analysis using fluorescence-activated cell sorting assay. Subcutaneously injected VEGF induced in vivo neovascularization was studied with the BMM plug assay. RESULTS. VEGF-induced subconfluent MREC proliferation, migration, and tube formation were significantly inhibited by α1(IV)NC1 at 1 μM (P < 0.001). α1(IV)NC1 induced MREC apoptosis is mediated by inhibition of Bcl-2 and Bcl-xL expression and activation of caspase-3/PARP through FAK/p38-MAPK signaling. In addition, α1(IV)NC1 dose dependently inhibited VEGF-mediated neovascularization in vivo. CONCLUSIONS. α1(IV)NC1 inhibited VEGF-mediated angiogenesis by promoting apoptosis and caspase-3/PARP activation and by negatively impacting FAK/p38-MAPK phosphorylation, Bcl-2, and Bcl-xL expression leading to MREC death. The endothelial- specific inhibitory actions of recombinant α1(IV)NC1 may be of benefit in the treatment of a variety of eye diseases with a neovascular component.",
author = "Boosani, {Chandra S.} and Narasimharao Nalabothula and Veerendra Munugalavadla and Cosgrove, {Dominic E} and Keshamoun, {Venkateshwar G.} and Nader Sheibani and Akulapalli Sudhakar",
year = "2009",
month = "12",
day = "1",
doi = "10.1167/iovs.09-3473",
language = "English (US)",
volume = "50",
pages = "4567--4575",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "10",

}

TY - JOUR

T1 - FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by α1(IV)NC1

AU - Boosani, Chandra S.

AU - Nalabothula, Narasimharao

AU - Munugalavadla, Veerendra

AU - Cosgrove, Dominic E

AU - Keshamoun, Venkateshwar G.

AU - Sheibani, Nader

AU - Sudhakar, Akulapalli

PY - 2009/12/1

Y1 - 2009/12/1

N2 - PURPOSE. To determine the impact of the antiangiogenic factor α1(IV)NC1 on vascular endothelial growth factor-mediated proangiogenic activity in mouse retinal endothelial cells (MRECs). METHODS. Primary culture of MRECs was established as previously described and was used to determine the effects of α1(IV)NC1 on the proangiogenic activity of VEGF. Cell proliferation was evaluated using [3H]-thymidine incorporation and 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide colorimetric assays. Cell migration was determined using modified Boyden chamber and scratch wound assays and tube formation was assessed on basement membrane matrix (BMM). Intracellular signaling events Bcl-2/Bcl-xL and caspase-3/poly (ADP-ribose) polymerase (PARP) activities were evaluated in cells stimulated with VEGF and plated on type IV collagencoated dishes. Apoptosis was assessed by measuring caspase activity and by performing quantitative fluorescence analysis using fluorescence-activated cell sorting assay. Subcutaneously injected VEGF induced in vivo neovascularization was studied with the BMM plug assay. RESULTS. VEGF-induced subconfluent MREC proliferation, migration, and tube formation were significantly inhibited by α1(IV)NC1 at 1 μM (P < 0.001). α1(IV)NC1 induced MREC apoptosis is mediated by inhibition of Bcl-2 and Bcl-xL expression and activation of caspase-3/PARP through FAK/p38-MAPK signaling. In addition, α1(IV)NC1 dose dependently inhibited VEGF-mediated neovascularization in vivo. CONCLUSIONS. α1(IV)NC1 inhibited VEGF-mediated angiogenesis by promoting apoptosis and caspase-3/PARP activation and by negatively impacting FAK/p38-MAPK phosphorylation, Bcl-2, and Bcl-xL expression leading to MREC death. The endothelial- specific inhibitory actions of recombinant α1(IV)NC1 may be of benefit in the treatment of a variety of eye diseases with a neovascular component.

AB - PURPOSE. To determine the impact of the antiangiogenic factor α1(IV)NC1 on vascular endothelial growth factor-mediated proangiogenic activity in mouse retinal endothelial cells (MRECs). METHODS. Primary culture of MRECs was established as previously described and was used to determine the effects of α1(IV)NC1 on the proangiogenic activity of VEGF. Cell proliferation was evaluated using [3H]-thymidine incorporation and 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide colorimetric assays. Cell migration was determined using modified Boyden chamber and scratch wound assays and tube formation was assessed on basement membrane matrix (BMM). Intracellular signaling events Bcl-2/Bcl-xL and caspase-3/poly (ADP-ribose) polymerase (PARP) activities were evaluated in cells stimulated with VEGF and plated on type IV collagencoated dishes. Apoptosis was assessed by measuring caspase activity and by performing quantitative fluorescence analysis using fluorescence-activated cell sorting assay. Subcutaneously injected VEGF induced in vivo neovascularization was studied with the BMM plug assay. RESULTS. VEGF-induced subconfluent MREC proliferation, migration, and tube formation were significantly inhibited by α1(IV)NC1 at 1 μM (P < 0.001). α1(IV)NC1 induced MREC apoptosis is mediated by inhibition of Bcl-2 and Bcl-xL expression and activation of caspase-3/PARP through FAK/p38-MAPK signaling. In addition, α1(IV)NC1 dose dependently inhibited VEGF-mediated neovascularization in vivo. CONCLUSIONS. α1(IV)NC1 inhibited VEGF-mediated angiogenesis by promoting apoptosis and caspase-3/PARP activation and by negatively impacting FAK/p38-MAPK phosphorylation, Bcl-2, and Bcl-xL expression leading to MREC death. The endothelial- specific inhibitory actions of recombinant α1(IV)NC1 may be of benefit in the treatment of a variety of eye diseases with a neovascular component.

UR - http://www.scopus.com/inward/record.url?scp=70349572805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349572805&partnerID=8YFLogxK

U2 - 10.1167/iovs.09-3473

DO - 10.1167/iovs.09-3473

M3 - Article

VL - 50

SP - 4567

EP - 4575

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 10

ER -